Boston Scientific Corp
(BSP:B1SX34)
R$
419.42
7.62 (1.85%)
Market Cap: 616.62 Bil
Enterprise Value: 664.97 Bil
PE Ratio: 64.71
PB Ratio: 5.68
GF Score: 67/100 - Q1 2024 Boston Scientific Corp Earnings Call TranscriptApr 24, 2024R$375.1 (+6.22%)Earnings
- Q4 2023 Boston Scientific Corp Earnings Call TranscriptJan 31, 2024R$313.19 (+2.96%)Earnings
- Boston Scientific Corp at Stifel Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Boston Scientific Corp Earnings Call TranscriptOct 26, 2023R$250.75 (+0.20%)Earnings
- Boston Scientific Corp Investor Day TranscriptSep 20, 2023
- Q2 2023 Boston Scientific Corp Earnings Call TranscriptJul 27, 2023R$249.5 (+0.81%)Earnings
- Boston Scientific Corp at Sanford C Bernstein Strategic Decisions Conference TranscriptMay 31, 2023
- Q1 2023 Boston Scientific Corp Earnings Call TranscriptApr 26, 2023R$256.36 (-1.08%)Earnings
- Boston Scientific Corp at Citi Healthcare & Medtech Conference TranscriptMar 01, 2023
- Q4 2022 Boston Scientific Corp Earnings Call TranscriptFeb 01, 2023R$239.28 (+1.99%)Earnings
- Boston Scientific Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Boston Scientific Corp at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 30, 2022
- Boston Scientific Corp at Stifel Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 Boston Scientific Corp Earnings Call TranscriptOct 26, 2022R$225.37 (+2.65%)Earnings
- Boston Scientific Corp Investor Update at TCT TranscriptSep 18, 2022
- Boston Scientific Corp at Wells Fargo Healthcare Conference TranscriptSep 07, 2022
- Q2 2022 Boston Scientific Corp Earnings Call TranscriptJul 27, 2022R$212.6 (+5.31%)Earnings
- Boston Scientific Corp at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Boston Scientific Corp Earnings Call TranscriptApr 27, 2022R$214.34 (+0.69%)Earnings
- Boston Scientific Corp at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 17, 2022
- Q4 2021 Boston Scientific Corp Earnings Call TranscriptFeb 02, 2022R$219.19 (-4.02%)Earnings
- Boston Scientific Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Boston Scientific Corp at Evercore ISI HealthCONx Virtual Conference TranscriptDec 01, 2021
- Boston Scientific Corp at Stifel Healthcare Conference (Virtual) TranscriptNov 15, 2021
- Q3 2021 Boston Scientific Corp Earnings Call TranscriptOct 27, 2021R$244.47 (-1.12%)Earnings
- Boston Scientific Corp Investor Day TranscriptSep 22, 2021
- Q2 2021 Boston Scientific Corp Earnings Call TranscriptJul 27, 2021R$235.06 (+3.23%)Earnings
- Boston Scientific Corp at Sanford C Bernstein Strategic Decisions Conference (Virtual) TranscriptJun 04, 2021
- Boston Scientific Corp at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Boston Scientific Corp at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Boston Scientific Corp Annual Shareholders Meeting TranscriptMay 06, 2021
- Boston Scientific Corp at Truist Securities Life Sciences Summit TranscriptMay 05, 2021
- Q1 2021 Boston Scientific Corp Earnings Call TranscriptApr 28, 2021R$239.2 (+2.57%)Earnings
- Boston Scientific Corp at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Boston Scientific Corp at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Q4 2020 Boston Scientific Corp Earnings Call TranscriptFeb 03, 2021R$199 (+0.56%)Earnings
- Boston Scientific Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Boston Scientific Corp at Evercore ISI HealthCONx Conference TranscriptDec 01, 2020
- Boston Scientific Corp at Stifel Virtual Healthcare Conference TranscriptNov 18, 2020
- Boston Scientific Corp to Discuss LOTUS Edgeâ„¢ Aortic Valve System Voluntary Recall and Product Discontinuation - Conference Call TranscriptNov 17, 2020
- Boston Scientific Corp at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 12, 2020
- Q3 2020 Boston Scientific Corp Earnings Call TranscriptOct 28, 2020R$205.6Earnings
- Boston Scientific Corp Investor Update at Transcatheter Cardiovascular Therapeutics 2020 TranscriptOct 15, 2020
- Boston Scientific Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Boston Scientific Corp at Wells Fargo Virtual Healthcare Conference TranscriptSep 09, 2020
- Q2 2020 BioTelemetry Inc Earnings and Sales Agent Agreement with Boston Scientific Corp Call TranscriptJul 30, 2020
- Q2 2020 Boston Scientific Corp Earnings Call TranscriptJul 29, 2020R$203.38 (+1.56%)Earnings
- Boston Scientific Corp at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- Boston Scientific Corp at Sanford C Bernstein Strategic Decisions Conference TranscriptMay 27, 2020
- Boston Scientific Corp at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Boston Scientific Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Boston Scientific Corp Annual Shareholders Meeting TranscriptMay 07, 2020
- Q1 2020 Boston Scientific Corp Earnings Call TranscriptApr 29, 2020R$201.36Earnings
- Boston Scientific Corp at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Boston Scientific Corp at Cowen HealthCare Conference TranscriptMar 03, 2020
- Boston Scientific Corp at Leerink Global Healthcare Conference TranscriptFeb 27, 2020
- Q4 2019 Boston Scientific Corp Earnings Call TranscriptFeb 05, 2020R$180.72Earnings
- Boston Scientific Corp Investor Update at NANS 2020 TranscriptJan 24, 2020
- Boston Scientific Corp at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Boston Scientific Corp at Piper Jaffray Healthcare Conference TranscriptDec 05, 2019
- Boston Scientific Corp at Evercore HealthCONx Conference TranscriptDec 04, 2019
- Boston Scientific Corp at Stifel Healthcare Conference TranscriptNov 19, 2019
- Boston Scientific Corp at Stephens Investor Conference TranscriptNov 14, 2019
- Boston Scientific Corp at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Boston Scientific Corp Investor Update at Vascular Interventional Advances Conference (VIVA) TranscriptNov 05, 2019
- Q3 2019 Boston Scientific Corp Earnings Call TranscriptOct 23, 2019Earnings
- Boston Scientific Corp Investor Update at TCT 2019 TranscriptSep 27, 2019
- Boston Scientific Corp at Wells Fargo Healthcare Conference TranscriptSep 05, 2019
- Boston Scientific Corp at Canaccord Genuity Growth Conference TranscriptAug 08, 2019
- Q2 2019 Boston Scientific Corp Earnings Call TranscriptJul 24, 2019Earnings
- Boston Scientific Corp Investor Day TranscriptJun 26, 2019
- Boston Scientific Corp at Sanford C Bernstein Strategic Decisions Conference TranscriptMay 29, 2019
- Boston Scientific Corp at UBS Global Healthcare Conference TranscriptMay 21, 2019
- Boston Scientific Corporation Presents at Digestive Disease Week (DDW) 2019, May-20-2019 07:30 AM TranscriptMay 20, 2019
- Boston Scientific Corp at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Boston Scientific Corp Investor Update at HRS 2019 TranscriptMay 09, 2019
- Q1 2019 Boston Scientific Corp Earnings Call TranscriptApr 24, 2019Earnings
- Boston Scientific Corp at Cowen Health Care Conference TranscriptMar 13, 2019
- Boston Scientific Corp at Leerink Partners Global Healthcare Conference TranscriptFeb 28, 2019
- Q4 2018 Boston Scientific Corp Earnings Call TranscriptFeb 06, 2019Earnings
Boston Scientific Corp at SVB Leerink Global Healthcare (Virtual) Transcript
Feb 17, 2022 / 02:20PM GMT
Release Date Price:
R$220.07
(-2.77%)
Danielle Joy Antalffy
SVB Leerink LLC, Research Division - MD of Medical Supplies and Devices & Senior Analyst
Good morning, everyone. Thank you for joining us for day 2 of the company fireside chat for the SVB Leerink Global Healthcare Conference. I am Danielle Antalffy. I'm the med tech analyst here at Leerink, and we are very lucky to have with us Boston Scientific. We have Dan Brennan, CFO; and also Lauren Tengler, Head of Investor Relations. So I will just launch right into Q&A. Dan, if that's okay.
Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO
Sure.
Questions & Answers
Danielle Joy Antalffy
SVB Leerink LLC, Research Division - MD of Medical Supplies and Devices & Senior Analyst
So let's start with 2022 guidance, the sense is that it did disappoint some, but you have historically tried to be as conservative as possible. Tell me if I'm wrong in characterizing it that way. But can you talk about your approach to arriving at the 2022 sales growth and EPS guidance
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)